Subchronic Toxicity
Subchronic Toxicity is a toxicological assessment category characterized by adverse health effects resulting from repeated exposure to a pharmaceutical agent over a duration typically ranging from one to three months, distinguishing it from acute or chronic toxicity evaluations by its intermediate exposure period.
145
Publications
5.8K
Citations
574
Authors
181
Institutions
Publications per year
2017–2026
10
145
1–5 of 145
574
5
h-index
National Institute of Environmental Health Sciences, United States
4 publications · 146 citations
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 574
181
Environmental Protection Agency
Washington, United States
8 h-index
10 publications
357 citations

Research Triangle Park Foundation
Durham, United States
7 h-index
13 publications
577 citations
DuPont (United States)
Wilmington, United States
7 h-index
12 publications
308 citations
Dow Chemical (United States)
Midland, United States
6 h-index
20 publications
842 citations
University of Kansas Medical Center
Kansas City, United States
5 h-index
13 publications
474 citations

Chonnam National University
Gwangju, South Korea
4 h-index
12 publications
220 citations
Shell (United States)
Houston, United States
4 h-index
4 publications
109 citations
National Institute of Health Sciences
Tokyo, Japan
4 h-index
26 publications
1.5K citations
1–8 of 181
28 publications · 1.3K citations
20
h-index
22 publications · 668 citations
15
h-index
TAAP · 11 publications · 398 citations
11
h-index
RTP · 12 publications · 443 citations
11
h-index
6 publications · 178 citations
6
h-index
1–5